$LCTC

Lifeloc Technologies, Inc

Lifeloc Technologies develops, manufactures and markets fuel-cell-based portable handheld and fixed-station breathalyzers, along with related accessories, supplies, services and training. Its customers include law enforcement, corrections, workplace, OEM and consumer markets. Products include the FC Series and Workplace Series breath testers, Sentinel alcohol screening stations, and EASYCAL calibration stations. Lifeloc also sells components to other manufacturers and offers instrument service, recalibration, training and user certification. Its Lifeloc University platform provides online training. Lifeloc is developing SpinDetect, a lab-on-a-disk platform for rapid drug testing, initially focused on oral-fluid detection. It sells globally through distributors and directly to users, with workplace and international sales primarily through distributors, and law enforcement, corrections and OEM sales primarily direct. Lifeloc is headquartered in Wheat Ridge, Colorado.

1
1
2

No SEC Form 4 filings for $LCTC in the last 30 days.

See all $LCTC insider activity →
Med

Lifeloc Reports Third Quarter 2026 Results

Lifeloc Technologies, Inc (LCTC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Lifeloc Reports Third Quarter 2026 Results WHEAT RIDGE, Colo., November 16, 2026 -- Lifeloc Technologies, Inc. (OTCID: LCTC), a global leader in the development and manufacturing of breath alcohol and drug testing devices, has announced financial results for the quar

Lifeloc Technologies, Inc. (LCTC) Delays SpinDetect Launch to Q4 2027

Lifeloc Technologies (LCTC) reported Q3 2026 revenue growth of 12% to $2.5M and a reduced net loss of $85K. The company delayed SpinDetect's commercial launch to Q4 2027 from Q1 2027. The delay impacts the timeline for the drug-testing platform's market introduction.

LCTC sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 4 news stories mentioning LCTC (Lifeloc Technologies, Inc). Coverage has skewed bearish: 1 bullish, 1 neutral, and 2 bearish.

Recent LCTC coverage spans earnings, insider activity and financial news.

What's driving LCTC

  • Q3 results show improving gross margin and revenue growth, while the key incremental catalyst is the delayed SpinDetect launch timeline.

    SEC EDGAR 8-K · Nov 16, 2026

  • Negative GAAP EPS with modest year-over-year revenue growth suggests profitability remains weak, which can pressure valuation multiples until margins improve.

    seekingalpha.com · Nov 16, 2026

  • Delay of the flagship product reduces near‑term growth expectations.

    tradingview.com · Nov 16, 2026

  • Q2 shows improving gross margin and revenue growth, but continued net losses and ongoing R&D spend keep near-term risk elevated.

    SEC EDGAR 8-K · Aug 14, 2026

  • Q2 financials and gross margin improvement support a modest fundamental read-through, but the OTC microcap’s losses and R&D spend keep risk elevated.

    finanznachrichten.de · Aug 13, 2026

AlphAI scores every news story that mentions LCTC with an AI model for sentiment and relevance, and aggregates insider trades from Lifeloc Technologies, Inc's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $LCTC

Score
$LCTCMedEarnings

Lifeloc Reports Third Quarter 2026 Results

Lifeloc Technologies, Inc (LCTC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Lifeloc Reports Third Quarter 2026 Results WHEAT RIDGE, Colo., November 16, 2026 -- Lifeloc Technologies, Inc. (OTCID: LCTC), a global leader in the development and manufacturing of breath alcohol and drug testing devices, has announced financial results for the quar

$LCTCMedEarnings

Lifeloc Reports Second Quarter 2026 Results

Lifeloc Technologies, Inc (LCTC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Lifeloc Reports Second Quarter 2026 Results WHEAT RIDGE, Colo., August 13, 2026 -- Lifeloc Technologies, Inc. (OTCID: LCTC), a global leader in the development and manufacturing of breath alcohol and drug testing devices, has announced financial results for the quart

Lifeloc Technologies, Inc.: Lifeloc Completes SpinDetect Disk Production Tooling, Commissions Cleanroom, and Outlines Staged Commercial Rollout

Lifeloc Technologies (OTC Pink: LCTC) said it completed SpinDetect consumable disk production tooling, produced first-article disks, and finished minor mold changes after initial testing. The company commissioned a cleanroom with automated reagent dispensing to support validation and early manufacturing. It plans staged commercialization: qualitative delta-9-THC pass/fail first, with launch targeted for late 2026/early 2027 and an initial U.S. reader list price around $7,495.

$LCTCLowShareholder vote

Lifeloc Technologies, Inc (LCTC): Submission of Matters to a Vote of Security Holders

Lifeloc Technologies, Inc (LCTC) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Current Report false 0001493137 0001493137 2026-06-03 2026-06-03 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 193

Related tickers